Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: December 2012
-
December 11, 2012 – Preissuance Prior Art Submissions at the USPTO — Best Practices for Third-Party Challenges to Patent Applications and Monitoring Competition (Strafford) – 1:00 – 2:30 pm (EST) December 12, 2012 – Saving the Best for Last: Top 10 Things In-House Counsel Need to Do to Prepare for the AIA's March 2013 Deadline…
-
By Kevin E. Noonan — Lurking in H.R. 6621, a bill entitled "To correct and improve certain provisions of the Leahy-Smith America Invents Act and title 35, United States Code" and introduced on November 30th by Rep. Lamar Smith (R-TX) is a provision that would substantively affect (and effectively eliminate) patent rights for the ~200…
-
By Kevin E. Noonan — There are more issues in patent law that the Supreme Court may consider than those raised by Association for Molecular Pathology v. Myriad Genetics, and as if to illustrate that point, the Solicitor General filed his brief at the end of November in Retractable Techs., Inc. v. Becton, Dickinson & Co. …
-
By Donald Zuhn — In a notice published last week in the Federal Register (77 Fed. Reg. 71170), the U.S. Patent and Trademark Office announced that it was interested in gathering "additional information" on independent second opinion genetic diagnostic testing for purposes of preparing a report on the subject as required by the Leahy-Smith America…
-
By Ann Palma — About Court Report Supplement: Periodically, we will report on biotech and pharma cases that were inadvertently omitted from our Court Report column. TriPharma, LLC v. First Fruits Business Ministry LLC et al.8:12-cv-404; filed March 14, 2012 in the Central District of California • Plaintiff: TriPharma, LLC• Defendants: First Fruits Business Ministry…
-
By Jenny Donald — Two UK applications were rejected by a UK examiner on the ground that they constituted the 'use of human embryos for industrial or commercial purposes', which is excluded from patentability. The applications met the other requirements for patentability. A final decision on these applications was suspended until the referred questions on…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Takeda Pharmaceutical Co. et al. v. Lupin Ltd. et al.3:12-cv-07333; filed November 29, 2012 in the District Court of New Jersey • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals U.S.A., Inc; Takeda Pharmaceuticals LLC; Takeda Pharmaceuticals…
-
December 3-5, 2012 – Drug and Medical Device Litigation*** (American Conference Institute) – New York, NY December 4-5, 2012 – Paragraph IV Disputes*** (American Conference Institute) – San Francisco, CA December 11, 2012 – Preissuance Prior Art Submissions at the USPTO — Best Practices for Third-Party Challenges to Patent Applications and Monitoring Competition (Strafford) –…
Patent Docs 